Skip to content

CorMedix CRMD Accrued interest

Accrued interest at other companies

Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$5.27M0.0%
TFX
TeleflexTFX
$16.48M-3.2%
Phathom Pharmaceuticals, Inc. logo
Phathom Pharmaceuticals, Inc.PHAT
$1.68M-7.0%
Medline, Inc.
 logo
Medline, Inc. MDLN
Solventum logo
SolventumSOLV

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:InterestPayableCurrent.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's accrued interest.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's accrued interest?
CorMedix (CRMD) reported accrued interest of $1.01M in Q1 2026.
What does accrued interest mean?
Interest expense accrued but not yet paid on outstanding debt obligations, based on contractual interest rates and time elapsed.